| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-31 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-27 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.51 | 2e-25 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.36 | 8e-25 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-22 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-21 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-20 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-18 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-18 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-18 |